ENDLOS-TURBO PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 05:04:56 2024-05-29 EDT | ||
| 11.8 EUR | +0.08% |
|
| Current month | -3.91% | ||
| 1 month | -7.17% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-29 | 11.8 | +0.08% |
| 24-05-28 | 11.79 | +0.43% |
| 24-05-27 | 11.74 | -0.34% |
| 24-05-24 | 11.78 | +0.17% |
| 24-05-23 | 11.76 | +5.95% |
Delayed Quote Deutsche Boerse AG
Last update May 29, 2024 at 05:04 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DW6DR9 |
| ISIN | DE000DW6DR94 |
| Date issued | 2022-10-04 |
| Strike | 343.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 7.15 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.61 € |
|---|---|
| Lowest since issue | 1.66 € |
| Spread | 0.09 € |
| Spread % | 0.76% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
218.7
USD
Average target price
286.1
USD
Spread / Average Target
+30.78%
- Stock Market
- Certificates
- Certificat
